Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 5, 2013, Pages 1043-1048

  Löhr, Iren Høyland ^a,b   Rettedal, Siren ^a   Natås, Olav B ^a   Naseer, Umaer ^c,d   Øymar, Knut ^a,b   Sundsfjord, Arnfinn ^c,d  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Children; Enterobacteriaceae; ESBLs; Extended spectrum lactamases; Risk factors

Indexed keywords

AGAR; ANTIBIOTIC AGENT; BETA LACTAMASE CTX M;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CESAREAN SECTION; DNA SEQUENCE; EPIDEMIC; FECAL CARRIAGE; FECES; FECES ANALYSIS; FEMALE; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITALIZATION; HOUSEHOLD; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RECTUM; RISK FACTOR;

BETA-LACTAMASES; CARRIER STATE; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; FAMILY HEALTH; FECES; FEMALE; HUMANS; INFANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; RECTUM;

EID: 84877152204     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks502     Document Type: Article

References (40)

1. Paterson DL, Bonomo RA. Extended-spectrum b-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-86.
2. Jacoby GA, Munoz-Price LS. The new b-lactamases. N Engl J Med 2005; 352: 380-91.
3. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBLproducing Enterobacteriaceae in Europe. Euro Surveill 2008; 13: pii=19044.
4. Naseer U, Sundsfjord A. The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist 2011; 17: 83-97.
5. Livermore DM, Canton R, Gniadkowski M et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59: 165-74.
6. Bonnet R. Growing group of extended-spectrum b-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
7. Nyberg SD, Osterblad M, Hakanen AJ et al. Detection and molecular genetics of extended-spectrum b-lactamases among cefuroximeresistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scand J Infect Dis 2007; 39: 417-24.
8. Kjerulf A, Hansen DS, Sandvang D et al. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS 2008; 116: 118-24.
9. Onnberg A, Molling P, Zimmermann J et al. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum b-lactamases with focus on CTX-M in a lowendemic area in Sweden. APMIS 2011; 119: 287-95.
10. Naseer U, Natas OB, Haldorsen BC et al. Nosocomial outbreak of CTX-M-15-producing E. coli in Norway. APMIS 2007; 115: 120-6.
11. Lytsy B, Sandegren L, Tano E et al. The first major extended-spectrum b-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008; 116: 302-8.
12. Bagattini M, Crivaro V, Di Popolo A et al. Molecular epidemiology of extended-spectrum b-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Antimicrob Chemother 2006; 57: 979-82.
13. Abdel-Hady H, Hawas S, El-Daker M et al. Extended-spectrum b-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. J Perinatol 2008; 28: 685-90.
14. Rastogi V, Nirwan PS, Jain S et al. Nosocomial outbreak of septicaemia in neonatal intensive care unit due to extended spectrum b-lactamase producing Klebsiella pneumoniae showing multiple mechanisms of drug resistance. Indian J Med Microbiol 2010; 28: 380-4.
15. Rettedal S, Lohr IH, Natas O et al. First outbreak of extendedspectrum b-lactamase-producing Klebsiella pneumoniae in a Norwegian neonatal intensive care unit; associated with contaminated breast milk and resolved by strict cohorting. APMIS 2012; 120: 612-21.
16. Valverde A, Grill F, Coque TM et al. High rate of intestinal colonization with extended-spectrum-b-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 2008; 46: 2796-9.
17. Rodriguez-Bano J, Lopez-Cerero L, Navarro MD et al. Faecal carriage of extended-spectrum b-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008; 62: 1142-9.
18. Lo WU, Ho PL, Chow KH et al. Fecal carriage of CTXM type extended-spectrum b-lactamase-producing organisms by children and their household contacts. J Infect 2010; 60: 286-92.
19. Alsterlund R, Axelsson C, Olsson-Liljequist B. Long-term carriage of extended-spectrum b-lactamase-producing Escherichia coli. Scand J Infect Dis 2012; 44: 51-4.
20. Tande D, Boisrame-Gastrin S, Munck MR et al. Intrafamilial transmission of extended-spectrum-b-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children. J Antimicrob Chemother 2010; 65: 859-65.
21. Tangden T, Cars O, Melhus A et al. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extendedspectrum b-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-8.
22. Titelman E, Iversen A, Kais M et al. Duration of faecal carriage of ESBL-producing E. coli and K. pneumoniae following first-time clinical infection. Clin Microbiol Infect 2012; 18 Suppl 1: 459.
23. Papst L, Beovic B, Seme K. Duration of colonisation with extendedspectrum b-lactamase-producing enterobacteria. Clin Microbiol Infect 2012; 18 Suppl 1: 463.
24. Tham J, Walder M, Melander E et al. Duration of colonization with extended-spectrum b-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis 2012; 44: 573-7.
25. Tofteland S, Haldorsen B, Dahl KH et al. Effects of phenotype and genotype on methods for detection of extended-spectrum-blactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 2007; 45: 199-205.
26. Norwegian Working Group on Antibiotics (NWGA). Brytningspunkttabeller for tolkening av MIC-verdier og sonediametre. http://www.unn.no/getfile.php/UNN-Internett/Fagfolk/www.antibiotikaresistens.no/AFA/Brytningspunkter/AFAs%20kliniske%20brytningspunkter%20v%202.1.1%202011-03-28.pdf (30 September 2012, date last accessed).
27. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v1.3_pdf.pdf (30 September 2012, date last accessed).
28. Naseer U, Haldorsen B, Tofteland S et al. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS 2009; 117: 526-36.
29. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
30. Penders J, Thijs C, Vink C et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118: 511-21.
31. Fanaro S, Chierici R, Guerrini P et al. Intestinal microflora in early infancy: composition and development. Acta Paediatr 2003; 91: 48-55.
32. Westerbeek EA, van den Berg A, Lafeber HN et al. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr 2006; 25: 361-8.
33. Eggesbo M, Moen B, Peddada S et al. Development of gut microbiota in infants not exposed to medical interventions. APMIS 2011; 119: 17-35.
34. Bennet R, Eriksson M, Nord CE et al. Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr Infect Dis 1986; 5: 533-9.
35. Biasucci G, Rubini M, Riboni S et al. Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev 2010; 86 Suppl 1: 13-5.
36. Gronlund MM, Lehtonen OP, Eerola E et al. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999; 28: 19-25.
37. Huurre A, Kalliomaki M, Rautava S et al. Mode of delivery-effects on gut microbiota and humoral immunity. Neonatology 2008; 93: 236-40.
38. Bennet R, Eriksson M, Nord CE. The fecal microflora of 1-3-month-old infants during treatment with eight oral antibiotics. Infection 2002; 30: 158-60.
39. Tanaka S, Kobayashi T, Songjinda P et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol 2009; 56: 80-7.
40. Rettedal S, Löhr IH, Natås O et al. Risk factors for acquisition of CTX-M-15 extended-spectrum b-lactamase-producing Klebsiella pneumoniae during an outbreak in a neonatal intensive care unit in Norway. Scand J Infect Dis 2012; doi:10.3109/00365548.2012.713116.